![LCS23_Gio-template-Mailchimp-1200x400-4 LCS23_Gio-template-Mailchimp-1200x400-4](https://clinicalvalue.com/wp-content/uploads/2023/05/LCS23_Gio-template-Mailchimp-1200x400-4.png)
Quick Summary
Dr. Amit Singal and Dr. Peter Jepson review the latest developments in risk-based surveillance and the early detection of hepatocellular carcinoma during the EASL Liver Cancer Summit 2023, in light of the recent EASL policy statement for patients with cirrhosis.